Skip to main content
Clinical Trials/NCT03722082
NCT03722082UnknownNot Applicable

Study About the Effectiveness of Enhancing Cognitive Reserve in Children, Adolescents and Young Adults at Genetic Risk for Psychosis

Hospital Clinic of Barcelona1 site in 1 country173 target enrollmentStarted: October 1, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
173
Locations
1
Primary Endpoint
Cognitive reserve

Study Overview

Brief Summary

The high hereditary component and the contribution of neurodevelopmental processes in bipolar disorder and schizophrenia means implies the children of these patients are considered a high risk population for both diseases and therefore a very adequate sample for the study of vulnerability markers to both disorders. To date there is no previous literature on the psychological approach of children and adolescents of bipolar or schizophrenic patients. The concept of cognitive reserve (CR) was initially developed in the field of dementia, it assumes that people with the same brain damage may have different clinical manifestations depending on their ability to compensate for this damage, so a greater cognitive reserve will entail a greater capacity to compensate the alterations and difficulties due to the pathology. Enhancing CR in high genetic risk population could help the acquisition of skills that help compensate the clinical, cognitive and neuroimaging alterations and ultimately help in the prevention of the development of pathologies for those with higher risk.This study aims to develop and apply a psychological program in order to enhance cognitive reserve (CR) in child, adolescent and young adults offspring of patients diagnosed with schizophrenia or bipolar disorder (SZBP-OFF).

Detailed Description

The project will have two main objectives: to test the effectiveness of the psychological program and to test if the observed improvements are stable over time (nine months of follow-up). A sample of 108 SZBP-OFF and 52 community controls will be included. Both groups will be assessed with clinical scales, neuropsychological, CR and neuroimaging assessments at baseline. Then, the SZBP-OFF group will be randomized to psychological program to enhance CR (N= 54) or to support treatment (N=54). SZBP-OFF subjects will be evaluated with clinical, CR, neuropsychological and neuroimaging tests after the psychological intervention and at nine months follow-up in order to assess if the obtained results are stable over time. The investigators hypothesize that SZBP-OFF will show lower CR scores and higher percentages of psychopathology, cognitive difficulties and brain abnormalities. The investigators also hypothesize that SZBP-OFF who received the psychological intervention will increase their CR and will decrease the severity of the observed difficulties (in clinical, neuropsychological, CR and neuroimaging areas). These results will be stable in the nine month follow-up assessment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Outcomes Assessor)

Masking Description

Primary outcome

Eligibility Criteria

Ages
6 Years to 25 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •(Off-spring of patients) Inclusion criteria (Offsprings)
  • •Children, adolescents or young adults of both genders aged from 6 to 25, with the father and / or mother with schizophrenia, schizoaffective disorder or bipolar disorder according to DSM-IV criteria.
  • •Informed consent signed by their parents or legal guardians by adolescents if they are under 12 years old.
  • •Inclusion criteria (Controls)
  • •Children, adolescents or young adults of both genders between the ages of 6 and 25 years.
  • •No history of psychotic disorder or bipolar disorder in first and second degree relatives.
  • •Consent signed by the parents or legal guardians if they are under 12 years old.

Exclusion Criteria

  • •Mental retardation with impaired functioning and presence of neurological disorder or history of traumatic brain injury with loss of consciousness.

Arms & Interventions

Enhancing cognitive reserve intervention

Experimental

This intervention focuses in the improvement of academic skills, the increase of leisure activities and the improvement of neurocognitive functions with the ultimate goal of improving daily functioning. This intervention is based on ecological tasks that will be carried out in two areas, both in the hospital and at home. Most of the techniques are based on: pencil and paper tasks, with audiovisual and virtual reality support, telephone applications and group activities. The groups will be made with parents and children, adolescents and young adults separately being the content of the sessions the same but adapted to the age of the attendees.

Intervention: Enhancing Cognitive Reserve (Behavioral)

Supportive Intervention

Placebo Comparator

The participants will not receive any structured intervention focused to enhance cognitive reserve. The therapists will adopt a client-centred focus, meaning that whatever problems the patient presents will be dealt with by providing emotional support and general advise.

Intervention: Support intervention (Behavioral)

Outcomes

Primary Outcomes

Cognitive reserve

Time Frame: 3 months afther the intervention and 12 months after baseline

Changes in cognitive reserve assessed with a specific scale which assesses the most common proposed proxy indicators such as education-occupation' which is assessed taking into account the number of years of obligatory education that subjects completed and parent's educational level; and the lifetime school performance and lifetime participation in leisure, social and physical activities.

Secondary Outcomes

  • Bipolar Prodrome Symptom Interview and Scale_Prospective (BPSS_FP)(12 months after baseline)
  • Wisconsin Card Sorting Test(After the intervention (3 months) and 12 months after baseline)
  • Hamilton Depression Rating Scale (HDRS-21)(After the intervention (3 months) and 1 year after baseline)
  • Young Mania Rating Scale (YMRS)(After the intervention (3 months) and 1 year after baseline)
  • Neuroimage variables(After the intervention (3 months))
  • Continuous Performance Test(After the intervention (3 months) and 12 months after baseline)
  • Stroop Test(After the intervention (3 months) and 12 months after baseline)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Carla Torrent

Principal Investigator

Hospital Clinic of Barcelona

Study Sites (1)

Loading locations...

Similar Trials